PriceSensitive

ScreenPro (CSE:SCRN) completes over 24,000 COVID-19 tests in April

Health Care, Market News
CSE:SCRN
19 May 2021 08:45 (EDT)

ScreenPro (SCRN) received COVID-19 test orders for an additional 3 Film & TV productions, 1 in Toronto and 2 in Vancouver.

During the month of April, ScreenPro administered approximately 24,000 COVID-19 tests to personnel at 22 production companies in Toronto and Vancouver.

ScreenPro continues to have success with the 1copy™ COVID-19 qPCR Multi Kit, (1drop) supplied by Datametrex AI Limited (TSXV: DM). The manufacturer, 1drop Inc., has confirmed that the 1drop can identify the new variants, which is vital to stemming the third wave.

The film and TV production industry in Canada represents $8.92 billion in production volume, and full-time equivalent jobs represent 179,000 workers. 

“With feature-length movies,episodic series productions and pilot season quickly ramping up in Toronto and Vancouver, and with multiple mutant variants, we feel that this will continue expanding the COVID-19 screening business for the film and TV industries. We are proud to be able to help the industry and the citizens to create safer working environment with our dedicated team and their capability to deliver in timely fashion to minimize the risk,” said Andrew Ryu, CEO of ScreenPro Security.

ScreenPro is a screening and medical technology company. ScreenPro provides turnkey screening solutions with alerting software, GoStop. ScreenPro’s unique access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in Vancouver and Ontario allow ScreenPro to be a nationwide provider of full-service testing solutions.

ScreenPro has its own nursing professionals, and access to high-quality PPEs to ensure that its clients are protected in all aspects of their testing needs. 

ScreenPro Security Inc. (SCRN) opened trading at C$0.08 per share.

Related News